The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 06, 2024

Filed:

Mar. 13, 2019
Applicant:

Otsuka Pharmaceutical Factory, Inc., Naruto, JP;

Inventors:

Seiji Tani, Naruto, JP;

Seiji Fujita, Naruto, JP;

Teru Nakai, Naruto, JP;

Yasuhiro Kiuchi, Naruto, JP;

Miyuki Yamanaka, Naruto, JP;

Yui Hayashi, Naruto, JP;

Hiroshi Kanno, Naruto, JP;

Yu Saruwatari, Naruto, JP;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/00 (2006.01); A23L 33/175 (2016.01); A23L 33/115 (2016.01); A23L 33/16 (2016.01); A61J 1/20 (2006.01); A61K 9/107 (2006.01); A61K 35/57 (2015.01); A61K 36/48 (2006.01); A61K 47/02 (2006.01); A61K 47/12 (2006.01); A61K 47/18 (2017.01); A61K 47/20 (2006.01); A61K 47/22 (2006.01);
U.S. Cl.
CPC ...
A61K 9/0029 (2013.01); A23L 33/115 (2016.08); A23L 33/16 (2016.08); A23L 33/175 (2016.08); A61J 1/2093 (2013.01); A61K 9/107 (2013.01); A61K 35/57 (2013.01); A61K 36/48 (2013.01); A61K 47/02 (2013.01); A61K 47/12 (2013.01); A61K 47/183 (2013.01); A61K 47/20 (2013.01); A61K 47/22 (2013.01); A23V 2002/00 (2013.01);
Abstract

The present invention provides an infusion preparation that is inhibited from generation of unwanted insoluble matter after mixing of two liquids of the infusion preparation in long-term storage. More specifically, the present invention provides an infusion preparation comprising two chambers separated by a communicably openable partition, a first chamber containing a first-chamber infusion comprising a fat emulsion and further comprising at least one member selected from the group consisting of amino acids that have a buffer action, divalent organic acids, and trivalent organic acids, a second chamber containing a second-chamber infusion comprising an amino acid and at least calcium as an electrolyte, wherein a total concentration of the amino acids that have a buffer action, divalent organic acids, and trivalent organic acids in the first-chamber infusion is 0.15 to 0.5 g/L, and a mixture of the first- and second-chamber infusions has a pH of 6.53 or less as measured 48 hours after the partition is communicably opened.


Find Patent Forward Citations

Tani, Seiji. (2024). Transfusion preparation (U.S. Patent No. 11890372). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/11890372

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…